CUSIP: 89374L104
Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
52,925,180
-
Share change
-
+992,735
-
Total reported value
-
$524,479,642
-
Price per share
-
$9.97
-
Number of holders
-
74
-
Value change
-
+$10,598,429
-
Number of buys
-
37
-
Number of sells
-
33
Institutional Holders of TRANSLATE BIO INC - COM (TBIO) as of Q1 2020
As of 31 Mar 2020,
TRANSLATE BIO INC - COM (TBIO) was held by
74 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,925,180 shares.
The largest 10 holders included
BAUPOST GROUP LLC/MA, FMR LLC, Atlas Venture Advisors, Inc., RTW INVESTMENTS, LP, BlackRock Inc., Omega Fund Management, LLC, FEDERATED HERMES, INC., FRAZIER MANAGEMENT LLC, Camber Capital Management LP, and VANGUARD GROUP INC.
This page lists
74
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.